Home › Funds › DIADEMA PARTNERS LP › TENX
DIADEMA PARTNERS LP position in TENX
TENAX THERAPEUTICS INC · Health Care
DIADEMA PARTNERS LP reported holding 307,000 shares of TENX (TENAX THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.5M, representing 0.97% of its reported portfolio and ranking #29 among its reported holdings. DIADEMA PARTNERS LP has disclosed TENX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DIADEMA PARTNERS LP's TENX position evolved
DIADEMA PARTNERS LP first disclosed a stake in TENX in Q4 2025 at 243,170 shares (US$3.0M). The position peaked in Q2 2026 at 307,000 shares, worth US$4.5M. Across 3 filings, DIADEMA PARTNERS LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 307,000 shares valued at US$4.5M — an increase of 127,262 shares quarter over quarter.. Notable position changes include a 26% trim in Q1 2026 (shares fell 9% over the following quarter), a 71% increase in Q2 2026 (shares fell 87% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 243.17K | $2.96M | New |
| Q1 2026 | 179.74K | $2.87M | Reduce |
| Q2 2026 | 307.00K | $4.47M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TENX and 13F data
TENX (TENAX THERAPEUTICS INC) is a Health Care company. 103 other funds we track also report a position in TENX — the largest reported positions include Vivo Capital, LLC (US$36.4M), Stonepine Capital Management, LLC (US$9.6M), Sofinnova Investments, Inc. (US$7.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TENX
- Vivo Capital, LLC 2.50M sh · $36.38M · Q2 2026
- Stonepine Capital Management, LLC 660.00K sh · $9.60M · Q2 2026
- Sofinnova Investments, Inc. 500.04K sh · $7.28M · Q2 2026
- BVF INC/IL 339.55K sh · $4.94M · Q2 2026
- Avidity Partners Management LP 265.93K sh · $3.87M · Q2 2026
- Verdad Advisers, LP 123.17K sh · $1.79M · Q2 2026
- Tetragon Partners GP Ltd 75.10K sh · $1.09M · Q2 2026
- Creek Drive Management Group LLC 74.00K sh · $1.08M · Q2 2026
- Velan Capital Investment Management LP 68.70K sh · $999.59K · Q2 2026
- Artia Global Partners LP 42.08K sh · $612.26K · Q2 2026
More on DIADEMA PARTNERS LP
FAQ
How long has DIADEMA PARTNERS LP held TENX?
DIADEMA PARTNERS LP has disclosed TENX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is DIADEMA PARTNERS LP's current position in TENX?
As of Q2 2026, DIADEMA PARTNERS LP holds 307.00K shares of TENX (TENAX THERAPEUTICS INC), valued at $4.47M, representing 0.97% of its reported portfolio and ranking #29.
Has DIADEMA PARTNERS LP been buying or selling TENX?
In the latest 13F filing (Q2 2026), DIADEMA PARTNERS LP increased its position in TENX. The position peaked in Q2 2026 at 307.00K shares.
Which other funds hold TENX?
Other major institutional holders of TENX include Vivo Capital, LLC, Stonepine Capital Management, LLC, Sofinnova Investments, Inc., among 103 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.